Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Shen

Orthopaedic Surgery Louisville, CO Medical Doctor

NPI 1912931973 CMS profile 86222

80 Health Park Dr, Suite 230, Louisville, CO 80027

Open in the dashboard

General payments

$359,206

723 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Shen of Louisville, CO is reported in the CMS Open Payments database as having received $359,206 across 723 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,815 41
2024 General $40,468 94
2023 General $47,847 102
2022 General $66,129 112
2021 General $37,841 95
2020 General $81,755 124
2019 General $80,351 155

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Shen
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Michael Shen were reported at $4,815. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Michael Shen Orthopaedic Surgery median Middle half National median
2019 $80,351 $644 $140–$2,844 $163
2020 $81,755 $312 $75–$1,860 $114
2021 $37,841 $520 $117–$2,495 $132
2022 $66,129 $598 $128–$2,731 $149
2023 $47,847 $461 $128–$2,264 $160
2024 $40,468 $497 $134–$2,475 $164
2025 $4,815 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $186,336 237 payments
  2. Zimvie Inc. $108,665 161 payments
  3. Alphatec Spine, Inc $38,990 185 payments
  4. Highridge Medical LLC $16,648 35 payments
  5. Orthofix Medical, Inc. $2,093 15 payments
  6. Medical Device Business Services, Inc. $1,414 9 payments
  7. Medtronic, Inc. $1,265 10 payments
  8. Stryker Corporation $1,132 16 payments
  9. DePuy Synthes Sales Inc. $922 20 payments
  10. Medtronic USA, Inc. $385 7 payments
  11. Other $1,356 28 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $310,317 290 payments
  2. Travel and Lodging $29,045 107 payments
  3. Food and Beverage $19,780 320 payments
  4. Education $65 6 payments
Products named General payments · program years 2019–2025
  1. Mobi-C Spine $141,277 175 payments
  2. Mobi-C Spine $96,125 136 payments
  3. Mobi-C Spine $19,696 27 payments
  4. Other - Miscellaneous $18,125 71 payments
  5. MOBI-C PLUG & FIT US $14,507 29 payments
  6. PD-Spine-New Product $13,031 15 payments
  7. Vital $11,325 17 payments
  8. TrellOss $9,375 7 payments
  9. Solus ALIF $9,055 29 payments
  10. ROI-C $7,590 7 payments
  11. Other $116,900 305 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

147

Median for Orthopedic Surgery: 203

Drug cost

$1,007

Median for Orthopedic Surgery: $1,433

Branded share of claims

12.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 29 $234
Methocarbamol Generic 33 $230
Methylprednisolone Generic 31 $229
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 19 $129
Ondansetron Hcl Generic 20 $124
Ibuprofen Generic 15 $61

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 38 billing codes

Paid by Medicare

$103,523

Medicare's payments for the services billed

Medicare patients

255

Average age 73

Services billed

835

148 women, 107 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 67%
Ischemic heart disease 25%
Depression 25%
Diabetes 20%
Osteoporosis 17%
Chronic kidney disease 13%
COPD 13%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

723 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record